WallStreetZenWallStreetZen

NASDAQ: HLTH
Cue Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for HLTH

Based on 2 analysts offering 12 month price targets for Cue Health Inc.
Min Forecast
$0.75+25%
Avg Forecast
$1.88+212.5%
Max Forecast
$3.00+400%

Should I buy or sell HLTH stock?

Based on 2 analysts offering ratings for Cue Health Inc.
Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HLTH stock forecasts and price targets.

HLTH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Goldman Sachs
Bottom 3%
3
HoldDowngrades$0.75+25.00%2023-06-02
BTIG
Top 31%
70
Strong BuyMaintains$3.00+400.00%2023-05-15

1 of 1

Forecast return on equity

Is HLTH forecast to generate an efficient return?
Company
-52.29%
Industry
7.08%
Market
14.03%
HLTH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HLTH forecast to generate an efficient return on assets?
Company
-42.6%
Industry
4.83%
HLTH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HLTH revenue growth forecast

How is HLTH forecast to perform vs Health Information Services companies and vs the US market?
Company
22.22%
Industry
17.72%
Market
16.73%
HLTH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HLTH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HLTH vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
HLTH$0.60$1.88+212.50%Buy
STRM$1.52N/AN/A
FORA$2.56N/AN/A
BEAT$2.24$6.78+202.46%Strong Buy
UTRS$0.29$1.00+241.30%Strong Buy
View Top Health Information Service Stocks

Cue Health Stock Forecast FAQ

Is Cue Health Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: HLTH) stock is to Buy HLTH stock.

Out of 2 analysts, 1 (50%) are recommending HLTH as a Strong Buy, 0 (0%) are recommending HLTH as a Buy, 1 (50%) are recommending HLTH as a Hold, 0 (0%) are recommending HLTH as a Sell, and 0 (0%) are recommending HLTH as a Strong Sell.

If you're new to stock investing, here's how to buy Cue Health stock.

What is HLTH's forecast return on equity (ROE) for 2023-2024?

(NASDAQ: HLTH) forecast ROE is -52.29%, which is considered weak.

What is HLTH's Price Target?

According to 2 Wall Street analysts that have issued a 1 year HLTH price target, the average HLTH price target is $1.88, with the highest HLTH stock price forecast at $3.00 and the lowest HLTH stock price forecast at $0.75.

On average, Wall Street analysts predict that Cue Health's share price could reach $1.88 by Jun 2, 2024. The average Cue Health stock price prediction forecasts a potential upside of 212.5% from the current HLTH share price of $0.60.

What is HLTH's forecast return on assets (ROA) for 2023-2024?

(NASDAQ: HLTH) forecast ROA is -42.6%, which is lower than the forecast US Health Information Services industry average of 4.83%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.